Objectives: To determine the prevalence of 'hypertriglyceridemic waist' (HTGW) in Oji-Cree, to examine its interaction with hepatic nuclear factor-1a (HNF1A) in association with type 2 diabetes, and to characterize its putative genetic determinants. Method: The presence or absence of HTGW was determined in 522 Oji-Cree subjects (223 males, 299 females), X18 years of age, in whom physical measurements and fasting plasma analyte concentrations were gathered, and a 75-g oral glucose tolerance test was administered, as part of a cross-sectional study. Subjects were genotyped for HNF1A codon 319, angiotensinogen (AGT) codons 174 and 235, G-protein b3-subunit (GNB3) nucleotide 825, fatty acid-binding protein (FABP2) codon 54, nucleotides À455 and À482 of the apolipoprotein (apo) C-III (APOC3) promoter, and a 5-bp insertion/deletion polymorphism within the 3 0 -untranslated region of protein phosphatase 1 regulatory subunit 3 (PPP1R3). Results: The unadjusted prevalence of HTGW in Oji-Cree adults was 20.5%, with more males affected than females (27.8 vs 15.1%, P ¼ 0.0004). Logistic regression analysis, adjusted for age and gender, showed type 2 diabetes was associated with both HNF1A G319S (odds ratio (OR) 4.85, 95% CI 2.45, 9.58) and HTGW (OR 4.96, 95% CI 2.49, 9.88). When the HNF1A mutation and HTGW were present in combination, the OR for type 2 diabetes was markedly increased (OR 43.2, 95% CI 12.4, 150). In women only, both GNB3 825C4T and FABP2 A54T genotypes were significantly associated with HTGW (OR 2.02, 95% CI 1.01, 4.05 and OR 1.95, 95% CI 1.01, 3.74, respectively). Conclusions: HTGW is prevalent in Oji-Cree, especially in men. The ORs for type 2 diabetes were similar (B5-fold) for subjects with either the presence of HTGW or the private HNF1A G319S mutation. These two independent risk factors acted synergistically to confer an even greater increased risk of type 2 diabetes.
Introduction
The development of screening tools to better identify subjects at risk of cardiovascular disease (CVD) and diabetes has been a recent focus for clinical research, highlighted by defining the 'metabolic syndrome' (MetS) in 2001. 1 MetS is a strong predictor of both diabetes 2 and CVD, 3 yet there is also evidence to suggest that a triad of nontraditional metabolic risk factors -namely elevated plasma concentrations of insulin, apolipoprotein (apo) B, and small, dense, LDL particles -may be a more powerful predictor of coronary heart disease (CHD) than traditional lipid risk factors. 4 However, these markers are not routinely available in many clinical settings. Thus, Lemieux et al. 5 showed that two easily determinable clinical measurements, namely waist circumference and fasting plasma triglyceride concentrations -also called the 'hypertriglyceridemic waist' (HTGW) phenotypeare a very good surrogate marker for men with the nontraditional atherogenic triad (480% concordance). Also, HTGW has been associated with insulin resistance, 6 atherogenic and diabetogenic risk factors, 7, 8 and coronary artery disease, 5 and predicted CVD events. 4, 9 While associations with CVD and associated risk factors have previously been studied in subjects with HTGW, there are few data regarding its association with diabetes. Type 2 diabetes has emerged as a modern health crisis for aboriginal Canadians. 10 Among the Oji-Cree of Ontario, the combined prevalence of impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) has been reported at an astonishing B40%. 11 Both genetic susceptibility, largely mediated through a private mutation in HNF1A encoding hepatic nuclear factor-1a, 12, 13 and a 'westernization' of lifestyle over the past 50 years, 14, 15 are major contributing factors. Alongside this rising tide of diabetes has been the recent doubling of hospitalizations for CHD among Oji-Cree, despite declining rates in the general population. 16 We have recently reported that MetS is highly prevalent in the Oji-Cree, and a modified MetS definition (excluding fasting glucose) showed association with T2DM, particularly in the combined presence of the HNF1A mutation (OR B20). 17 Considering the simplicity of the HTGW definition and its associations with diabetogenic risk factors, we were interested in evaluating the potential for this phenotype to identify asymptomatic Oji-Cree individuals at high risk for diabetes. In this current study, we determined the prevalence of HTGW and its components in the Sandy Lake Oji-Cree and explored its relationship with the HNF1A G319S mutation in association with T2DM. In addition, we investigated possible genetic determinants of HTGW, with a group of metabolically associated candidates analyzed previously in a study of MetS.
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Methods
Study subjects
Subjects for the current analysis were selected from the 1993-1995 Sandy Lake Health and Diabetes Project. 19 The
Oji-Cree community of Sandy Lake, Ontario, is located B2000 km northwest of Toronto in the subarctic boreal forest of central Canada. In all, 728 members of this community (72% of the total population) aged 10 years and above, participated in the original survey. Signed informed consent was obtained from all participants and the study was approved by both the Sandy Lake First Nation Band Council and the University of Toronto Ethics Review Committee. For this present study, individuals under the age of 18 were excluded, leaving a subset of 533 individuals, 522 (223 males, 299 females) of whom had a complete set of data for HTGW diagnosis.
Physical and biochemical analysis
Body weight, height, waist circumference, and blood pressure were measured by standardized procedures. 19 In all analyses, genotypes were introduced as dichotomous variables, assuming a dominant model for the less common allele. Thus, ORs were determined using a dominant model for the 'abnormal' allele, except for GNB3 825T, which was tested using a recessive model. Associations of genotypes with quantitative traits were tested by ANOVA, with sex, age, and BMI as independent variables. The dependent variables were systolic and diastolic blood pressure for AGT and GNB3, BMI for FABP2, plasma triglycerides for APOC3 and fasting glucose for PPP1R3. Plasma triglycerides were not normally distributed and were log transformed. Significance was calculated from type III sums of squares, which are most appropriate for unbalanced study designs and reports significance after all covariates are taken into account. Statistical significance was taken at nominal Po0.05 for all comparisons.
Results
HTGW in Oji-Cree
The distribution of HTGW and its components are described in Table 1 . Overall, abdominal obesity was more common than hypertriglyceridemia for the adults studied (70.1 vs 22.4%). There was no difference in the percentage of males and females with waist circumference X90 cm (P ¼ 0.37); however, hypertriglyceridemia was significantly more prevalent in males (29.2% for males vs 17.4% for females, P ¼ 0.0014). When comparing the combined presence/ absence of abdominal obesity and hypertriglyceridemia, the majority of the Oji-Cree adults (B50%) were defined as having waist circumference X90 cm and plasma triglycerides o2 mmol/l, with significantly more females in this category than males (53.5% females vs 44.4% males, P ¼ 0.039). The presence of hypertriglyceridemia alone was seen in only 1.9% of the adult population. The overall prevalence of HTGW in the Sandy Lake Oji-Cree adults was 20.5%. A significantly greater percentage of males had HTGW, compared to females (27.8 vs 15.1%, respectively, P ¼ 0.0004).
Metabolic risk profile of Oji-Cree adults according to HTGW status Table 2 shows the metabolic characteristics of subjects with and without HTGW, divided by gender. As expected, waist circumference and plasma triglycerides, which are defining components, were significantly elevated for subjects with HTGW. In addition, insulin and apo B -both components of the metabolic triad of nontraditional risk factors -were significantly elevated in subjects with HTGW (Po0.0001). Not surprisingly, other metabolic characteristics were also significantly different between subjects with and without HTGW. Plasma LDL cholesterol concentrations were higher and HDL cholesterol concentrations were lower for both males and females with HTGW. Diastolic blood pressure was elevated for males with HTGW, although no difference was seen for systolic blood pressure, nor were differences in blood pressure found for females according to HTGW status. In addition, BMI, fasting glucose, and plasma apo B and leptin were significantly elevated in males and females with HTGW, and in males, mean plasma apo A1 levels were reduced. Interestingly, although plasma HDL cholesterol was significantly different between females with and without HTGW, plasma apo A1 did not reflect this difference. However, for both genders, subjects with HTGW had a significantly higher apo B/apo A1 ratio.
Risk of T2DM and IGT
The effect of HTGW diagnosis, in combination with the HNF1A G319S mutation, was examined for the presence of T2DM and IGT (Table 3) . Subjects with neither HTGW nor the HNF1A mutation were the referent group. There was an thus, only results for the À455T4C SNP will be discussed hereafter, since the associations were virtually identical for both APOC3 SNP genotypes (data not shown). In contrast, only weak linkage disequilibrium was found between the AGT T174M and M235T genotypes (r ¼ À0.072, Po0.0001), so these genotypes were analyzed separately. No associations were found between HTGW and the selected genotypes -AGT T174M, AGT M235T, GNB3 825C4T, FABP2 A54T, APOC3 À455T4C, and PPP1R3 I/Din the overall adult population (data not shown). However, there were significant associations found for female subjects alone as the GNB3 825C4T and FABP2 A54T SNPs associated with HTGW (Table 4 ). The ORs and 95% CI for HTGW in GNB3 825T homozygotes and carriers of X1 copy of FABP2 T54 were 2.02 (1.01, 4.05) and 1.95 (1.01, 3.74), respectively. No significant associations with HTGW were found for any other genotype, including HNF1A G319S.
Among quantitative traits, elevated systolic blood pressure was significantly associated with homozygosity for AGT M235T (121716 vs 116713 mmHg, P ¼ 0.0093) and elevated 
Discussion
The principal novel findings of this study are: (1) HTGW prevalence of 20.5% for Oji-Cree adults according to 1993-1995 survey data; (2) significantly higher levels of hypertriglyceridemia and HTGW in Oji-Cree males compared to females; (3) metabolic triad features present in subjects with HTGW; (4) associations of both HTGW and HNF1A G319S with T2DM (both OR B5); (5) association of the combined presence of HNF1A G319S mutation and HTGW with T2DM (OR B40); and (6) associations of GNB3 825C4T and FABP2 A54T genotypes with HTGW in Oji-Cree female adults. Considering the potential impact of gender-based differences for waist circumference, a post hoc analysis of HTGW prevalence in the Sandy Lake population was carried out, using the gender-specific cutoffs from the NCEP ATP III guidelines (488 cm for females, 4102 cm for males) 1 The use of a single threshold value of waist circumference has been reported to accurately identify individuals with a critical amount of visceral adipose tissue, irrespective of sex or degree of obesity. 27 Hence for simplicity, we focused on using the waist circumference cutoff value of 90 cm, as described by Lemieux et al. 5 in the original definition of HTGW, as a singular standard for both males and females. In doing so, however, there is a potential possibility that we have overestimated the prevalence of abdominal obesity, and thus HTGW, among the men. Further research is required to establish ethnic-specific waist circumference cutoff points that are an accurate reflection of visceral obesity. Previous studies have found HTGW prevalence to be B49% for a cohort of French Canadian males 5 and B11%
for a group of healthy women with African-American, native American and Caucasian backgrounds. 7 However, no large general population studies have yet been reported for Hypertriglyceridemic waist in Oji-Cree RL Pollex et al HTGW, so it is impossible to make any meaningful comparisons with our data. Also, comparisons may not be appropriate due to a possible need for ethnic-specific cut points. MetS has been found to be more prevalent in female OjiCree adults than males; 17 however, the opposite was true for HTGW: significantly more males were affected. Males more commonly had plasma triglyceride concentrations X2 mmol/l (29.2% males vs 17.4% females, P ¼ 0.0014), and thus were more likely to be diagnosed as having HTGW. Further analysis showed that 76.4% of subjects (68.9% males, 86.7% females) with HTGW were also defined as having MetS and similarly, 82.2% of subjects without the HTGW phenotype were also without MetS diagnosis (data not shown). Thus, there is some overlap between individuals with HTGW and MetS, but this is incomplete, and B20% of Oji-Cree subjects with one diagnosis did not have the other. While characterizing these disparities is beyond the scope of this paper, it would be interesting to determine the clinical relevance, if any, for a diagnosis of HTGW in the absence of MetS and vice versa. Previously, Lemieux et al. 5 reported that B80% of Canadian men with HTGW also displayed the atherogenic triad comprising elevated fasting insulin and apo B levels as well as small, dense LDL particles (sLDL). Unfortunately, sLDL were not measured in the original study, but Oji-Cree subjects with HTGW did have significantly elevated fasting insulin and apo B concentrations by B1.7-and B1.4-fold, respectively. Other metabolic risk factors also tended to be worse among HTGW versus non-HTGW Oji-Cree subjects (Table 2) , as has been reported in other studies. 7, 8 According to BMI X30 kg/m 2 , the majority of subjects with HTGW were obese. Furthermore, there was a significant relationship found between HTGW and obesity status, with significantly more male and female subjects with HTGW classified as being obese (54.8% for males and 57.8% for females) compared to non-HTGW subjects (18.0% for males and 38.2% for females). Mean HDL-C concentrations for both males and females with HTGW met the NCEP ATP III criteria for being clinically low (o1.0 mmol/l for males and o1.3 mmol/l for females). 1 Mean fasting glucose concentrations were in the diabetic range: 7.8573.87 and 9.2075.13 mmol/l for males and females with HTGW, respectively. In addition, apo A1 concentrations were depressed in male subjects with HTGW, and apo B/apo A1 ratio, a significant heart disease risk factor, 28 were elevated for both genders.
In characterizing the relative contributions of two independent risk factors -namely, the genetic determinant, HNF1A G319S, and HTGW -to T2DM or IGT, we found that either the presence of the HNF1A G319S mutation alone or HTGW alone associated with a markedly increased risk for diabetes. However, most importantly, subjects with the inopportune combination of the HNF1A S319 allele and HTGW had the greatest OR for T2DM (OR 43.2, 95% 12.40, 150). We previously examined the contribution of a modified MetS (excluding fasting glucose), in combination with the HNF1A G319S genotype, to diabetes risk. 17 We found that MetS alone imparted an B5-fold increased risk of T2DM, similar to the risk observed for HTGW alone, indicating that elevated triglycerides plus increased abdominal obesity were as strong a risk factor for diabetes as were multiple metabolic risk factors in MetS. However, interestingly, the current analysis shows that the combined presence of HTGW and HNF1A S319 was twice as predictive of T2DM in comparison to the combined presence of MetS and HNF1A (OR 43.2 vs OR B20). 17 Owing to the cross-sectional nature of this study, care must be take in the interpretation of these results: the increased risk is purely an observed association with diabetes and is not predictive of diabetes onset. Despite this limitation, the study results reveal a unique relationship between HNF1A and HTGW and highlight the power of HTGW as a marker of diabetes risk. Finally, to find genetic determinants of HTGW, we selected candidate genes that had previously been found to have associations with various metabolic characteristics. In gender-specific analyses, female GNB3 825T homozygotes and female carriers of X1 copy of FABP2 T54 had significantly increased odds for HTGW (OR 2.02, 95% CI 1.01, 4.05, and OR 1.95, 95% CI 1.01, 3.74, respectively). Previous genetic research has already reported the existence of genes associated with both hypertriglyceridemia and obesity, such as lipoprotein lipase, 29 however to the best of our knowledge, this is the first genetic association study for the defined HTGW phenotype.
The T54 variant of FABP2 shows increased binding affinity and intestinal uptake of long chain fatty acids, 30, 31 and has previously been found to be associated with increased plasma triglyceride concentrations, 32 increased BMI and increased percent body fat. 23 Thus, an association might be expected between HTGW and FABP2. In contrast, no significant associations with HTGW were found for APOC3 promoter polymorphisms, which, like FABP2, have also been found to play a role in plasma triglyceride concentrations for the Oji-Cree. 24 However, it must be noted that the genetic associations found were marginal (P-values ¼ 0.044 and 0.047), due to the relatively small sample size and the complexity of HTGW trait, and thus other positive associations may have been missed due to these factors. The other SNP associated with HTGW for the female OjiCree was GNB3, a more surprising candidate, considering that the 825T allele has been found to be associated with lower systolic blood pressure. 22 However, the GNB3 825T allele, which encodes a variant associated with increased levels of G-protein activation, 33 has also been shown to be associated with measures of obesity and hypertriglyceridemia for other populations. 34, 35 Thus, GNB3 825C4T may also be modifying other metabolic factors in the Oji-Cree, in addition to its known impact on blood pressure. A post hoc analysis of female subjects divided by GNB3 825C4T genotype, however, failed to show any significant differences between subjects in terms of obesity measurements, Hypertriglyceridemic waist in Oji-Cree RL Pollex et al although plasma concentrations of apo B were elevated in 825T homozygotes (P ¼ 0.032). Alternatively, the genomic variant at GNB3 position 825 may be in linkage disequilibrium with another locus that is the cause of this association. In contrast to the female Oji-Cree adults, none of the five selected genes had any associations with HTGW in males. Certainly, there may be additional genes that have not yet been investigated, which play a greater role in the risk of HTGW for males. Gender-specific genetic factors associated with HTGW might underlie the observed gender differences in the prevalence of HTGW components as noted by the significantly higher levels of elevated triglyceride concentrations in males compared with females.
In summary, we have shown that HTGW is strongly associated with diabetes, especially when considered together with HNF1A G319S genotype. Having described the current state of HTGW in Oji-Cree, including its underlying genetic factors and strong association with diabetes, future research into the sensitivity and specificity of HTGW as a predictor of diabetes and CVD events will be essential for determining the effectiveness of its use in this community and/or clinical practice. A potential advantage of HTGW as a clinical tool is its ease of determination. With the worldwide continuous increase in obesity prevalence, it is important to develop easily applied markers and definitions of high-risk states in order to target preventative measures.
